Plain-English translation of NCT06400927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing a new tool called SIRIO-HF, an artificial intelligence-powered virtual assistant designed to help people manage heart failure after they leave the hospital. Researchers want to see if this assistant can help reduce how often patients need to visit the doctor and make care more consistent—while keeping patients safe and satisfied with their care.
Heart failure is a serious condition that requires close monitoring after diagnosis, but frequent doctor visits can be a burden for patients and healthcare systems. This study explores whether a virtual AI assistant can help bridge that gap by providing support between appointments without compromising safety or quality of care.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups: one group using the AI virtual assistant along with standard care, and the other group receiving standard care alone. The study will track your safety, how often you need doctor visits, how satisfied you are with your care, and whether the assistant helps reduce the burden of managing your condition. The study involves 60 participants total and will last for the duration of the pilot phase.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United Kingdom